Protein degradation has emerged as a promising new field of therapeutics. What are biophysical tools are employed for the characterisation of these drugs?

Fire and Mello’s research has unlocked a powerful new therapeutic technology: silencing genes with siRNA.

Our Discussion Group featured expert conversation on automation and synthesis from software to hardware, key challenges, and end goals.

Mcule is a leading chemical marketplace for drug discovery where you can order small-molecule samples from a high-quality database. We acquire the compounds from the manufacturers and deliver them in a consolidated package, in the format specified by you

A paper published in the Journal of Medicinal Chemistry highlights Cambridge, UK based biotech, Bicycle Therapeutics’ findings regarding bicycle toxin conjugate, BT8009.

Japanese-UK biotech Sosei Heptares are tackling the problem of stabilising GPCR structures with a view toward novel drug discovery endpoints.

Andrew Robertson, Vice President, Head of Global Regulatory Policy and Innovation at Takeda, talks about working with regulators and the current regulatory paradigm.

Helping unlock the promise of Cellular Therapies and Regenerative Medicines